NCT07120854Enrolling by invitation
Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.
Evaluation of a Decision Analysis Model in a Decision Aid for Fracture Prevention in Postmenopausal Women: Randomized Clinical Trial.
Source: ClinicalTrials.gov · Last updated 13 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Fragility fractures, often caused by low bone mineral density, are a major health concern for postmenopausal women. One way to prevent these fractures is by taking medication, but deciding whether to start treatment can be difficult due to potential risks and side effects. This study will test a web-based tool designed to help women make informed decisions about fracture prevention treatment. The tool provides information about the benefits and risks of treatment. Some women in the study will also receive additional support through a decision analysis report, which helps weigh different factors when making a choice. The study will examine whether using this tool improves decision-making, increases confidence in making a choice, and enhances satisfaction with the decision. It will also explore what factors influence women's decisions and at what level of risk they choose to start treatment. By understanding how decision aids impact choices, researchers aim to improve the way healthcare providers support patients in making informed decisions about their health.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 114 (estimated)
- First submitted
- 28 Jul 2025
- Start date
- 3 Apr 2025
- Primary completion date
- 20 Dec 2025
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Diseases
- Osteoporosis
- NCT number
- NCT07120854
What you commit to
- Study type: Interventional
- Planned participants: 114
- From 3 Apr 2025 to the primary completion date, 20 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- suffer from serious concomitant pathologies (cancer, chronic renal insufficiency, etc.)
- women under permanent treatment with glucocorticoids.
Other illness
- women with a history of fragility fracture
Lab values
- being treated with bisphosphonates or other osteoporosis drugs (except for vitamin D and calcium supplements
Who the study is looking for
- Postmenopausal women older than 50 years
- No medical history of fragility fractures
- With or without a BMD measurement performed
- Having been considered candidates to pharmacological treatment prevention for fragility fractures.
- A 10 year fracture risk assessment according to FRAX for Major fracture \>5%.
Age in the registry: 50 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Recerca Hospital de la Santa Creu i Sant Pau Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.